MR编号 | PT/H/0272/001 |
---|
药品名称 | Meropenem Kabi |
---|
活性成分 | - meropenem trihydrate 570.0 mg
|
---|
剂型 | Powder for solution for infusion/injection |
---|
上市许可持有人 | Fresenius Kabi Pharma Portugal, Lda |
---|
参考成员国 - 产品名称 | Portugal (PT) |
---|
互认成员国 - 产品名称 | - Germany (DE)
Meropenem Kabi 500 mg Pulver zur Herstellung einer Injektionslösung oder Infusionslösung - Denmark (DK)
- Belgium (BE)
- Netherlands (NL)
- Luxembourg (LU)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
Meropenem Kabi 500 mg Pulver zur Herstellung einer Injektionslösung oder Infusionslösung - Spain (ES)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
- Poland (PL)
- Lithuania (LT)
Meropenem Kabi 500 mg milteliai injekciniam ar infuziniam tirpalui - Estonia (EE)
MEROPENEM KABI 500 MG - Hungary (HU)
MEROPENEM KABI 500 mg por oldatos injekcióhoz vagy infúzióhoz - Cyprus (CY)
MEROPENEM KABI 500mg PWD FOR SOLUTION FOR INJECTION OR INFUSION - Czechia (CZ)
Meropenem Kabi 500 mg - Romania (RO)
Meropenem Kabi 500mg, pulbere pentru soluţie injectabilă sau perfuzabilă - Slovakia (SK)
Meropenem Kabi 500 mg - Slovenia (SI)
|
---|
许可日期 | 2010/06/09 |
---|
最近更新日期 | 2024/08/20 |
---|
药物ATC编码 | 申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|
|
---|